The idea that IMU will go through trials on Vaxinia and Azer-Cel and eventually FDA approvals seems absurd. As soon as Azer-Cel begins a combination trial with OnCARlytics in solid tumours and shows efficacy along with continued positive results in the MAST trial, I reckon it’s game over and we get the first offer for the company. It’s just how these things work, especially given promising results which we seem to be getting plenty of so far.
Remember the comment not so long ago when Leslie was sick and unable to present at an event - “…this is a 12 month play”.
Why IMU is a multi multi bagger, page-20225
-
- There are more pages in this discussion • 5,535 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.003(5.77%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.7¢ | 5.2¢ | $802.5K | 14.79M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 348447 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 1214875 | 6 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |